High-dose chemotherapy in the adjuvant treatment of breast cancer: Benefit/risk analysis

Cancer Control

Volumn 5, Issue 5, 1998, Pages 394-405

  Djulbegovic, B ^a   Hozo, I ^a   Fields, K K ^a   Sullivan, D ^a  

^a UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; BREAST CANCER; CALCULATION; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; HUMAN; RISK BENEFIT ANALYSIS;

EID: 0031739624     PISSN: 10732748     EISSN: None     Source Type: Journal    
DOI: 10.1177/107327489800500502     Document Type: Article

References (31)